908 Devices (MASS) Stock: Buy, Sell, or Hold?
MASS - 908 Devices Inc. Common Stock
$11.44
0.09 (0.79%)
â˛
5d:
+1.6%
30d:
-0.69%
90d:
+60.45%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When MASS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MASS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MASS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MASS is currently trading at $11.44, which is considered fair relative to its 30-day fair value range of $10.75 to $12.25.
Technical Outlook: Technically, MASS is in a strong uptrend. The price is currently testing key support at $11.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.38 (+17.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MASS is in a strong uptrend. The price is currently testing key support at $11.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.38 (+17.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.75 -
$12.25
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($13.38)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.75 -
$12.25
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$11.15
Resistance Level
$12.22
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-36.91
Wall Street Target
$13.38
(+17.8%)
Revenue Growth (YoY)
23.3%
Profit Margin
-57.0%
Share & Embed Analysis
Last updated: October 23, 2026 11:27 AM ET
Data refreshes hourly during market hours. Next update: 12:27 PM
Data refreshes hourly during market hours. Next update: 12:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 73 BUY |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 48 HOLD |
